Last reviewed · How we verify

Fe-ASP — Competitive Intelligence Brief

Fe-ASP (Fe-ASP) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Asparaginase conjugate. Area: Oncology.

marketed Asparaginase conjugate Asparagine synthetase (indirect target via asparagine depletion) Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Fe-ASP (Fe-ASP) — Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.. Fe-ASP is an iron-asparaginase conjugate that depletes asparagine while delivering iron supplementation.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Fe-ASP TARGET Fe-ASP Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. marketed Asparaginase conjugate Asparagine synthetase (indirect target via asparagine depletion)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Asparaginase conjugate class)

  1. Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Fe-ASP — Competitive Intelligence Brief. https://druglandscape.com/ci/fe-asp. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: